William Resides
Amministratore Delegato presso BIOREGENX, INC.
Patrimonio netto: 661 572 $ in data 31/05/2024
Profilo
William Resides was the founder of NuLife Sciences, Inc. (founded in 2019) and the current Chief Executive Officer & Director of BioRegenx, Inc. Mr. Resides is also the founder of BioRegenx, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOREGENX INC
2.16% | 08/03/2024 | 20 674 000 ( 2.16% ) | 661 568 $ | 31/05/2024 |
FINDIT INC PFD A
0.00% | 08/03/2024 | 112 ( 0.00% ) | 4 $ | 31/05/2024 |
Posizioni attive di William Resides
| Società | Posizione | Inizio |
|---|---|---|
| BIOREGENX, INC. | Amministratore Delegato | 08/03/2024 |
Precedenti posizioni note di William Resides
| Società | Posizione | Fine |
|---|---|---|
NuLife Sciences, Inc.
 NuLife Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services NuLife Sciences, Inc. a biomedical company, which engages in advancing human organ transplant and tissue repair technology, and medical research. The company was founded by Derek Cahill on October 15, 2013 and is headquartered in Newport Beach, CA. | Amministratore Delegato | - |
BioRegenx, Inc.
 BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
| Findit, Inc. | |
NuLife Sciences, Inc.
NuLife Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services NuLife Sciences, Inc. a biomedical company, which engages in advancing human organ transplant and tissue repair technology, and medical research. The company was founded by Derek Cahill on October 15, 2013 and is headquartered in Newport Beach, CA. | Commercial Services |
- Borsa valori
- Insiders
- William Resides
